Results 251 to 260 of about 10,554,980 (260)
Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response. [PDF]
Schmälter AK+8 more
europepmc +1 more source
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. [PDF]
Zheng Y+13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Immunology, 2009
CD4+ T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions.
T. Korn+3 more
semanticscholar +1 more source
CD4+ T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions.
T. Korn+3 more
semanticscholar +1 more source
The role of Th17 cells in psoriasis
Immunologic research, 2020Binbin Li+10 more
semanticscholar +1 more source
Targeting IL-17 and TH17 cells in chronic inflammation
Nature reviews. Drug discovery, 2012P. Miossec, J. Kolls
semanticscholar +1 more source
The pathogenicity of Th17 cells in autoimmune diseases
Seminars in Immunopathology, 2019K. Yasuda, Yusuke Takeuchi, K. Hirota
semanticscholar +1 more source
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
Nature Network Boston, 2013N. Komatsu+8 more
semanticscholar +1 more source
T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer
Archives of pharmacal research, 2019S. Chang
semanticscholar +1 more source